The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 25th 2024
As recommendations have become a commonplace expectation on radiology reports, is there a point where we are crossing the line?
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Cytogen to sever ties with Knoll Pharmaceutical after slow start for MoAb agent in U.S. market
April 20th 1994Firm also reports drop in European sales of OncoScintNuclear medicine'stepid acceptance of monoclonal-antibody-based imaging agents istaking its toll on MoAb pioneer Cytogen. The Princeton, NJ, companyannounced this month that sales of its
DOE proposes reactor switch in Mo-99 production effort
April 20th 1994Nuclear lab closing Omega West reactorThe Department of Energy is reconsidering its plan to restartthe Omega West reactor at Los Alamos National Laboratory in NewMexico in order to produce molybdenum-99, the raw material fortechnetium-99m. The
Weak nuclear medicine market prompts ADAC stock slide
April 6th 1994Drop in orders may signal prolonged slumpSales of nuclear medicine equipment remained level through muchof 1993, while orders in other modalities plunged due to apprehensionabout health-care reform. Nuclear medicine's easy ride could becoming
Neoprobe arranges Israeli agent plant
March 16th 1994Neoprobe is establishingan Israeli subsidiary to run a radiolabeling facility for monoclonalantibody agents used in its nuclear probe technology (see above).The U.S. firm signed a memorandum of understanding with the Israelifirm Rotem Industries in
ADAC patent suit turns tables on nuclear competitor Elscint
March 2nd 1994Underlying technology bought from PhilipsThe patent infringement legal dispute between nuclear medicinevendors ADAC Laboratories and Elscint took an unusual turn lastmonth. ADAC acquired patents from Philips Medical Systems relatingto gamma
Park absorbs Isis effort to launch digital camera
February 16th 1994Park Meditech of Toronto unified its corporate structure overthe past two months and gained a listing on the U.S. NASDAQ stockexchange (symbol: PMDTF) last week. The moves are part of Park'spositioning for a worldwide launch into the nuclear medicine
Nuclear sales shine in a declining market
December 15th 1993Nuclear medicine equipment vendors are having the last laugh overcritics who predicted in the 1980s the eventual demise of thegamma camera market. As 1993 comes to a close, it appears thatnuclear medicine will be the fastest growing segment of the
Canadian isotope spat could cause price hike
November 17th 1993Trouble is brewing again at a Canadian nuclear reactor that isthe source of much of the world's supply of molybdenum-99, theraw material for the nuclear medicine tracer technetium-99m. Thedispute could result in higher prices for a number of
Sopha parent will sell venture in low-field MRI
November 3rd 1993Sopha Medical Systems' short-lived effort to expand into the U.S.MRI market is about to come to an end. The nuclear camera andcomputer vendor's parent company is close to completing a dealto shed the MRI venture, according to Buster Houchins, vice
Cytogen restructures to focus on peptide agents
October 6th 1993Sluggish sales of its flagship monoclonal antibody nuclear imagingagent have prompted Cytogen to restructure operations with anemphasis on development of peptide-based agents. While the Princeton,NJ, company will continue to aggressively market its
Trionix opts out of RSNA exhibition
October 6th 1993Nuclear medicine camera vendor Trionix will forgo exhibiting atthis year's Radiological Society of North America conference infavor of more specialized nuclear medicine meetings. The Twinsburg,OH-based company, known for its towering exhibit booth, has
Nuclear medicine bucks imaging sluggishness
September 8th 1993While MRI procedures are slumping, the number of nuclear medicineprocedures, particularly in cardiac imaging, continues to rise.After plateauing for several years, nuclear medicine studies areincreasing in volume, according to John Vanden Brink,
Hitachi digital cameras pack dual-energy punch
August 11th 1993Demand for premium nuclear medicine cameras should increase assophisticated techniques such as dual-isotope and monoclonal antibodyimaging proliferate. Realizing the potential of these techniques,however, requires corresponding improvements in camera
Cast collimators offer nuclear edge
July 14th 1993Manufacturers of SPECT cameras might improve equipment performancewith an advanced microcast fanbeam collimator developed by NuclearFields. The technology creates ultra-high resolution nuclear imagesthrough the use of uniform casting technology and
Toshiba touts camera with 3-D video display
June 30th 1993Toshiba America Medical Systems used a little marketing pizzazzto unveil an adjustable-angle dual-head gamma camera as a work-in-progressat this month's Society of Nuclear Medicine meeting in Toronto.Rather than display an empty mock-up of the camera,
Elscint camera taps cardiac growth
June 30th 1993Elscint has targeted nuclear medicine's growing cardiology segmentwith a gamma camera unveiled at this month's Society of NuclearMedicine meeting in Toronto. Dubbed Apex SPX CardiaL, the fixed90´-angle, dual-head unit spearheads a general upgrade
Camtronics shops for OEM accounts
June 30th 1993Multiformat camera maker Camtronics Medical Systems is pursuingOEM partners for its newest camera, following the expiration ofa sole-source contract with GE Medical Systems. Camtronics wasat the Society of Nuclear Medicine meeting in Toronto this
Merger could establish new gamma camera vendor
June 16th 1993Medasys, a nuclear medicine computer manufacturer, and EncoreMedical Systems, a gamma camera refurbisher and reseller, haveagreed to merge. While details of the merger remain to be workedout and shareholder approval is required for both companies,
Antitrust rules tackle SPECT agent
June 16th 1993Nuclear medicine physicians have access to only one of two Foodand Drug Administration-approved SPECT brain agents because ofa combination of brain SPECT procedure sluggishness and U.S. antitrustregulations. Financial difficulties have apparently claimed
NRC license fee hikes squeeze nuclear medicine
June 2nd 1993A recent court decision has given the nuclear medicine communitya forum in which to challenge the Nuclear Regulatory Commission'scontroversial license fees for handling radioisotopes. Nuclearmedicine practitioners charge that NRC fees have skyrocketed
Senate hearing slams NRC medical regulation
May 19th 1993The regulation of medical radiation came under fire this monthat a Congressional hearing held to follow up on reports of treatmenterrors in radiation therapy and nuclear medicine. The hearingcould be the first step in an overhaul of the way in which
DOE action fires up NBTF project
April 21st 1993Nuclear medicine advocates are claiming victory after the U.S.Department of Energy last month requested $2 million to studythe creation of a National Biomedical Tracer Facility to produceradioisotopes. Such a study would be a major step toward securinga
Probe maker builds own MoAb agent
February 24th 1993Gamma cameras aren't the only nuclear detectors that will takeadvantage of targeted monoclonal antibody nuclear tracer technology.Nonimaging probes, such as those manufactured by Neoprobe andCare Wise Medical Products (SCAN 9/26/90 and 12/04/91), use
OncoScint nod opens door for U.S. MoAb imaging procedures
January 27th 1993After years of waiting, the U.S. nuclear medicine profession hasbeen granted access to tumor-targeted monoclonal antibody imagingagents for routine clinical use. Apart from its diagnostic benefits,monoclonal antibody technology offers the potential of
European MoAb takeoff slower than anticipated
October 21st 1992Faster review of monoclonal antibody imaging agents by Europeanregulatory authorities led many in the U.S. nuclear medicine fieldto look across the Atlantic for the first commercial success ofthis targeted tracer technology. Unfortunately, the European
ISIS prepares to market digital nuclear camera
September 3rd 1992Independent Scintillation Imaging Systems (ISIS) of Lachine, Quebec,will build a direct sales and marketing group headquartered outsideBoston to handle U.S. sales of its non-Anger, digital nuclearmedicine camera upon approval by the Food and Drug
Hearing highlights U.S. isotope shortage
August 26th 1992The U.S. Department of Energy wants to create a domestic sourcefor isotopes, both stable and radioactive. Witnesses at a Congressionalhearing on Aug. 12, however, criticized the DOE's efforts as inadequate. Nuclear medicine's dependence on a single
Strike threat at molybdenum plant in Canada alarms nuclear medicine
August 12th 1992Nuclear medicine averted a crisis last month when workers at theworld's main source of the raw material for technetium-99m settledcontract negotiations hours before a strike deadline. A laborwalkout would have caused a major shortage of the most